DK0652758T3 - Diferitoxin-vacciner - Google Patents
Diferitoxin-vaccinerInfo
- Publication number
- DK0652758T3 DK0652758T3 DK93913897T DK93913897T DK0652758T3 DK 0652758 T3 DK0652758 T3 DK 0652758T3 DK 93913897 T DK93913897 T DK 93913897T DK 93913897 T DK93913897 T DK 93913897T DK 0652758 T3 DK0652758 T3 DK 0652758T3
- Authority
- DK
- Denmark
- Prior art keywords
- diferitoxin
- vaccines
- diphtheria toxin
- dna
- glu
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90171292A | 1992-06-18 | 1992-06-18 | |
PCT/US1993/004606 WO1993025210A1 (en) | 1992-06-18 | 1993-05-17 | Diphtheria toxin vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0652758T3 true DK0652758T3 (da) | 2000-05-08 |
Family
ID=25414686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93913897T DK0652758T3 (da) | 1992-06-18 | 1993-05-17 | Diferitoxin-vacciner |
Country Status (12)
Country | Link |
---|---|
US (1) | US5601827A (da) |
EP (1) | EP0652758B1 (da) |
JP (1) | JP3428646B2 (da) |
AT (1) | ATE188508T1 (da) |
AU (1) | AU671649B2 (da) |
CA (1) | CA2138137C (da) |
DE (1) | DE69327534T2 (da) |
DK (1) | DK0652758T3 (da) |
ES (1) | ES2142346T3 (da) |
GR (1) | GR3032862T3 (da) |
PT (1) | PT652758E (da) |
WO (1) | WO1993025210A1 (da) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
US6455673B1 (en) | 1994-06-08 | 2002-09-24 | President And Fellows Of Harvard College | Multi-mutant diphtheria toxin vaccines |
US5917017A (en) * | 1994-06-08 | 1999-06-29 | President And Fellows Of Harvard College | Diphtheria toxin vaccines bearing a mutated R domain |
US5843462A (en) * | 1995-11-30 | 1998-12-01 | Regents Of The University Of Minnesota | Diphtheria toxin epitopes |
CA2253937A1 (en) * | 1996-05-10 | 1997-11-20 | Phylomed Corporation | Methods for oxidizing disulfide bonds using ozone |
US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US20060002959A1 (en) * | 1996-11-14 | 2006-01-05 | Government Of The United States | Skin-sctive adjuvants for transcutaneous immuization |
US5910306A (en) * | 1996-11-14 | 1999-06-08 | The United States Of America As Represented By The Secretary Of The Army | Transdermal delivery system for antigen |
US6797276B1 (en) * | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
US20040258703A1 (en) * | 1997-11-14 | 2004-12-23 | The Government Of The Us, As Represented By The Secretary Of The Army | Skin-active adjuvants for transcutaneous immunization |
US6787523B1 (en) * | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US6761888B1 (en) | 2000-05-26 | 2004-07-13 | Neuralab Limited | Passive immunization treatment of Alzheimer's disease |
TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US7790856B2 (en) * | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
US7588766B1 (en) | 2000-05-26 | 2009-09-15 | Elan Pharma International Limited | Treatment of amyloidogenic disease |
US20080050367A1 (en) * | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US20050059802A1 (en) * | 1998-04-07 | 2005-03-17 | Neuralab Ltd | Prevention and treatment of amyloidogenic disease |
WO2000061184A2 (en) * | 1999-04-08 | 2000-10-19 | Glenn Gregory M | Dry formulation for transcutaneous immunization |
GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
HU227893B1 (en) | 2000-06-29 | 2012-05-29 | Glaxosmithkline Biolog Sa | Vaccine compositions |
GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
TWI255272B (en) * | 2000-12-06 | 2006-05-21 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
ES2310201T3 (es) * | 2001-02-13 | 2009-01-01 | Government Of The United States Of America, As Represented By The Secretary Of The Army | Vacuna para inmunizacion transcutanea contra la diarrea de los viajeros. |
US20020177614A1 (en) * | 2001-03-23 | 2002-11-28 | Merril Carl R. | Methods for treating nuerodegenerative diseases including alzheimer's |
MY139983A (en) * | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
UA87453C2 (ru) * | 2003-02-01 | 2009-07-27 | Вайет | Применения фрагмента ав для лечения болезни альцгеймера |
TWI374893B (en) * | 2003-05-30 | 2012-10-21 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
GB0409745D0 (en) | 2004-04-30 | 2004-06-09 | Chiron Srl | Compositions including unconjugated carrier proteins |
ES2396555T3 (es) * | 2004-12-15 | 2013-02-22 | Janssen Alzheimer Immunotherapy | Anticuerpos que reconocen péptido beta amiloide |
JP2008523815A (ja) * | 2004-12-15 | 2008-07-10 | エラン ファーマ インターナショナル リミテッド | 認知の改善における使用のためのヒト化アミロイドβ抗体 |
JP2008524247A (ja) * | 2004-12-15 | 2008-07-10 | エラン ファーマ インターナショナル リミテッド | 認知の改善における使用のためのアミロイドβ抗体 |
GB0505996D0 (en) * | 2005-03-23 | 2005-04-27 | Glaxosmithkline Biolog Sa | Fermentation process |
US8007807B2 (en) | 2005-09-01 | 2011-08-30 | Novartis Vaccines And Diagnostics Gmbh | Multiple vaccination including serogroup C meningococcus |
CA2816182C (en) | 2005-12-22 | 2018-02-20 | Glaxosmithkline Biologicals S.A. | Pneumococcal polysaccharide conjugate vaccine |
EP2004225B1 (en) | 2006-03-22 | 2012-04-25 | Novartis AG | Regimens for immunisation with meningococcal conjugates |
US8784810B2 (en) * | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
EP2066344B2 (en) | 2006-09-07 | 2016-06-29 | GlaxoSmithKline Biologicals S.A. | Inactivated Poliovirus combination vaccine |
AU2008242648B2 (en) * | 2007-04-18 | 2013-09-12 | Janssen Alzheimer Immunotherapy | Prevention and treatment of cerebral amyloid angiopathy |
US8003097B2 (en) * | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
JP2010525035A (ja) | 2007-05-02 | 2010-07-22 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
GB2451928B (en) * | 2007-06-21 | 2011-03-16 | Angelica Therapeutics Inc | Modified Toxins |
KR101579947B1 (ko) | 2007-06-26 | 2015-12-28 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신 |
JP5889529B2 (ja) | 2007-07-27 | 2016-03-22 | ヤンセン・サイエンシズ・アイルランド・ユーシー | アミロイド原性疾患の処置 |
JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
EP2268297A4 (en) * | 2008-02-29 | 2011-11-16 | Angelica Therapeutics Inc | MODIFIED TOXINS |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
GB0917647D0 (en) | 2009-10-08 | 2009-11-25 | Glaxosmithkline Biolog Sa | Expression system |
NZ609567A (en) | 2010-11-05 | 2015-05-29 | Transbio Ltd | Markers of endothelial progenitor cells and uses thereof |
GB201105981D0 (en) | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
GB201106225D0 (en) | 2011-04-13 | 2011-05-25 | Glaxosmithkline Biolog Sa | Fermentation process |
CA2896157A1 (en) | 2012-12-27 | 2014-07-03 | Glycovaxyn Ag | Methods and compositions relating to crm197 |
MY172181A (en) | 2013-03-08 | 2019-11-15 | Janssen Vaccines & Prevention Bv | Acellular pertussis vaccine |
WO2014150600A2 (en) | 2013-03-15 | 2014-09-25 | Angelica Therapeutics, Inc. | Modified toxins |
GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
US20180064801A1 (en) | 2016-09-02 | 2018-03-08 | Glaxosmithkline Biologicals Sa | Vaccines for neisseria gonorrhoeae |
EP3894431A2 (en) | 2018-12-12 | 2021-10-20 | GlaxoSmithKline Biologicals SA | Modified carrier proteins for o-linked glycosylation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4709017A (en) | 1985-06-07 | 1987-11-24 | President And Fellows Of Harvard College | Modified toxic vaccines |
US4950740A (en) * | 1987-03-17 | 1990-08-21 | Cetus Corporation | Recombinant diphtheria vaccines |
US5149532A (en) * | 1989-11-01 | 1992-09-22 | Cedars Sinai Medical Center | Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms |
-
1993
- 1993-05-17 DE DE69327534T patent/DE69327534T2/de not_active Expired - Fee Related
- 1993-05-17 AU AU43762/93A patent/AU671649B2/en not_active Ceased
- 1993-05-17 ES ES93913897T patent/ES2142346T3/es not_active Expired - Lifetime
- 1993-05-17 PT PT93913897T patent/PT652758E/pt unknown
- 1993-05-17 WO PCT/US1993/004606 patent/WO1993025210A1/en active IP Right Grant
- 1993-05-17 AT AT93913897T patent/ATE188508T1/de not_active IP Right Cessation
- 1993-05-17 EP EP93913897A patent/EP0652758B1/en not_active Expired - Lifetime
- 1993-05-17 CA CA002138137A patent/CA2138137C/en not_active Expired - Fee Related
- 1993-05-17 DK DK93913897T patent/DK0652758T3/da active
- 1993-05-17 JP JP50147594A patent/JP3428646B2/ja not_active Expired - Fee Related
-
1995
- 1995-05-23 US US08/447,413 patent/US5601827A/en not_active Expired - Lifetime
-
2000
- 2000-03-03 GR GR20000400554T patent/GR3032862T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2142346T3 (es) | 2000-04-16 |
AU4376293A (en) | 1994-01-04 |
US5601827A (en) | 1997-02-11 |
EP0652758B1 (en) | 2000-01-05 |
DE69327534D1 (de) | 2000-02-10 |
AU671649B2 (en) | 1996-09-05 |
EP0652758A4 (en) | 1997-02-12 |
PT652758E (pt) | 2000-04-28 |
CA2138137C (en) | 2004-11-09 |
DE69327534T2 (de) | 2000-06-08 |
EP0652758A1 (en) | 1995-05-17 |
JP3428646B2 (ja) | 2003-07-22 |
CA2138137A1 (en) | 1993-12-23 |
JPH07507688A (ja) | 1995-08-31 |
GR3032862T3 (en) | 2000-07-31 |
ATE188508T1 (de) | 2000-01-15 |
WO1993025210A1 (en) | 1993-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0652758T3 (da) | Diferitoxin-vacciner | |
NO880354L (no) | Stoetsikker anordning for beskyttelse av styreenheter, spesielt fjernstyreenheter for tv. | |
DE68908909T2 (de) | Kabelbinder. | |
NO880945L (no) | Tuklingsavsloerende lukke. | |
DE3883699D1 (de) | Druckgasschalter. | |
JPS57176916A (en) | Novel thiolated polypeptide derived from tetanus toxin fragment, preparation and application | |
DE69002817D1 (de) | Vakzine. | |
GB2185266B (en) | Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes | |
DE3786910T2 (de) | Verschlüsselungssystem. | |
NO881288L (no) | Pasteurella-vaksine. | |
DE3873071D1 (de) | Emitterfolgerschaltung. | |
EP0042428A4 (en) | PURIFIED ANTIGEN OF HUMAN PROSTATE. | |
DE3874179T2 (de) | Fernbedienung. | |
FI882079A0 (fi) | Foerfarande foer framstaellning av en genetiskt kodbar polypeptid. | |
AU561683B2 (en) | Combined influenza, diphtheria, tetanus vaccine | |
NZ223624A (en) | Peptide immunogen from streptococcus mutans, vaccines and antibodies | |
DE58909071D1 (de) | Steckbarer quarz-infrarotstrahler. | |
EP0587765A4 (en) | INDUCTION OF AN IMMUNE REACTION TO TETANUS TOXIN BY ADMINISTRATION OF MYCOBACTERIA EXPRESSING TETANUS TOXIN OR FRAGMENTS THEREOF. | |
FI884855A0 (fi) | Preform foer en behaollare. | |
ATE96521T1 (de) | Druckdichte steckkupplung. | |
NO873949D0 (no) | Kobling av trykkgass. | |
NO166592C (no) | Vanntett, vaerbestandig og hovedsakelig uelastisk tekstil,fremgangsmaate til fremstilling derav og anvendelse av tekstilen. | |
IT8719793A0 (it) | Modulo autoimbustante. | |
IT8702907A0 (it) | Ferro da stiro a gas. | |
IT8704218V0 (it) | Ferro da stiro a gas. |